Bannaga A[au] - Search Results

Year	Number of Results
2001	1
2002	1
2013	2
2015	1
2016	1
2017	2
2019	2
2020	6
2021	10
2022	2

1

Lysosomal Zn²⁺ release triggers rapid, mitochondria-mediated, non-apoptotic cell death in metastatic melanoma.

Du W, Gu M, Hu M, Pinchi P, Chen W, Ryan M, Nold T, Bannaga A, Xu H. Du W, et al. Among authors: bannaga a. Cell Rep. 2021 Oct 19;37(3):109848. doi: 10.1016/j.celrep.2021.109848. Cell Rep. 2021. PMID: 34686351 Free PMC article.

2

Utility of volatile organic compounds as a diagnostic tool in preterm infants.

Wright H, Bannaga AS, Iriarte R, Mahmoud M, Arasaradnam RP. Wright H, et al. Among authors: bannaga as. Pediatr Res. 2021 Jan;89(2):263-268. doi: 10.1038/s41390-020-0828-3. Epub 2020 Mar 2. Pediatr Res. 2021. PMID: 32120380

3

Non-Invasive Detection and Staging of Colorectal Cancer Using a Portable Electronic Nose.

Tyagi H, Daulton E, Bannaga AS, Arasaradnam RP, Covington JA. Tyagi H, et al. Among authors: bannaga as. Sensors (Basel). 2021 Aug 12;21(16):5440. doi: 10.3390/s21165440. Sensors (Basel). 2021. PMID: 34450881 Free PMC article.

4

Pathophysiological Implications of Urinary Peptides in Hepatocellular Carcinoma.

Bannaga A, Metzger J, Voigtländer T, Pejchinovski M, Frantzi M, Book T, James S, Gopalakrishnan K, Mischak H, Manns MP, Arasaradnam RP. Bannaga A, et al. Cancers (Basel). 2021 Jul 27;13(15):3786. doi: 10.3390/cancers13153786. Cancers (Basel). 2021. PMID: 34359689 Free PMC article.

5

Unique methodological characteristics of the urine in volatile organic compound analysis.

Bannaga A, Chandrapalan S, McFarlane M, Arasaradnam RP. Bannaga A, et al. Med Hypotheses. 2021 Jan;146:110407. doi: 10.1016/j.mehy.2020.110407. Epub 2020 Nov 20. Med Hypotheses. 2021. PMID: 33272730 No abstract available.

6

Urinary Volatiles and Chemical Characterisation for the Non-Invasive Detection of Prostate and Bladder Cancers.

Tyagi H, Daulton E, Bannaga AS, Arasaradnam RP, Covington JA. Tyagi H, et al. Among authors: bannaga as. Biosensors (Basel). 2021 Nov 3;11(11):437. doi: 10.3390/bios11110437. Biosensors (Basel). 2021. PMID: 34821653 Free PMC article.

7

Inflammatory bowel disease and anxiety: links, risks, and challenges faced.

Bannaga AS, Selinger CP. Bannaga AS, et al. Clin Exp Gastroenterol. 2015 Mar 23;8:111-7. doi: 10.2147/CEG.S57982. eCollection 2015. Clin Exp Gastroenterol. 2015. PMID: 25848313 Free PMC article. Review.

8

Study in pink...rash!

Bannaga AS, Wiles S, Rahama O, Thaker H. Bannaga AS, et al. BMJ Case Rep. 2013 Sep 19;2013:bcr2013201319. doi: 10.1136/bcr-2013-201319. BMJ Case Rep. 2013. PMID: 24051153 Free PMC article. No abstract available.

9

Differentiating cancer types using a urine test for volatile organic compounds.

Bannaga AS, Kvasnik F, Persaud K, Arasaradnam RP. Bannaga AS, et al. J Breath Res. 2020 Dec 3;15(1):017102. doi: 10.1088/1752-7163/abc36b. J Breath Res. 2020. PMID: 33086204

10

Exploring how microbiome signatures change across inflammatory bowel disease conditions and disease locations.

Amos GCA, Sergaki C, Logan A, Iriarte R, Bannaga A, Chandrapalan S, Wellington EMH, Rijpkema S, Arasaradnam RP. Amos GCA, et al. Among authors: bannaga a. Sci Rep. 2021 Sep 21;11(1):18699. doi: 10.1038/s41598-021-96942-z. Sci Rep. 2021. PMID: 34548500 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results